Hat mitgewirkt an:
-
Entwicklung von Sendai-Virus-Vektoren für den In-vivo-Gentransfer
-
MicroRNA-sensitive oncolytic measles virus vectors for chemovirotherapy of pancreatic cancer
-
Virotherapy in Germany—Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies
-
Expression of artificial microRNA by oncolytic measles virus : a new strategy to overcome resistance mechanisms and enhance tumour cell killing